APA (7th ed.) Citation

H, E., ME, V., G, G., M, T., CM, K., T, J., . . . MPW, I. (2026). Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial. Clinical and translational radiation oncology, 60, 101191. https://doi.org/10.1016/j.ctro.2026.101191

Chicago Style (17th ed.) Citation

H, Eijkelenkamp, et al. "Safety and Early Organ Preservation Outcomes After Dose Escalation with MR-guided Radiotherapy for Rectal Cancer (preRADAR): A Phase I Trial." Clinical and Translational Radiation Oncology 60 (2026): 101191. https://doi.org/10.1016/j.ctro.2026.101191.

MLA (9th ed.) Citation

H, Eijkelenkamp, et al. "Safety and Early Organ Preservation Outcomes After Dose Escalation with MR-guided Radiotherapy for Rectal Cancer (preRADAR): A Phase I Trial." Clinical and Translational Radiation Oncology, vol. 60, 2026, p. 101191, https://doi.org/10.1016/j.ctro.2026.101191.